Sumathi Nambiar of FDA: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Dr. Sumathi Nambiar is Director of the Division of Anti-Infective Products, Office of Antimicrobial Products, since July 2013. Dr. Nambiar joined the Division of Anti-Infective Products in 2002. In her current role, Dr. Nambiar provides regulatory oversight for anti-infective products, including antibacterial, antifungal, and antiparasitic drugs. Dr. Nambiar is board-certified in pediatrics and pediatric infectious diseases. She completed her pediatric …

[WHITEPAPER] Rapid Molecular Diagnostics: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance

Rapid Molecular Diagnostics: Supporting CDC’s Four Core Actions to Fight Antimicrobial Resistance Download the whitepaper, courtesy of Cepheid here>> Some of the most widely used therapies in medicine, antibiotics have also steadily become some of the most improperly used treatments. Antibiotics have saved many lives and changed the face of medicine, but reliance upon them has also led to serious …

Judy Hackett of AstraZeneca: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Judy Hackett received her Pharmacy Degree from the University of Toronto.  She subsequently completed her M.B.A. at York University.  As well she has a graduate degree in Evaluation and Outcomes from the Faculty of Medicine,  University of Toronto. She began her career working in community pharmacy and then went onto work as a payer where she developed and managed drug …

Crestone: Novel Drug Discovery Programs for Infectious Diseases

“Crestone: Novel Drug Discovery Programs For Emerging Infectious Diseases”

Thale Jarvis of Crestone joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘novel drug discovery programs for emerging infectious diseases’. In this presentation, learn about CRS3123 for the treatment of Clostridium difficile infections. Download the presentation to understand more about: Crestone’s mission Clostridium difficile infection (CDI) CRS3123: Key advantages vs. competition …and much more! Get your copy …

Chris Houchens of BARDA: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Christopher Houchens, PhD joined the US Government’s Biomedical Advanced Research and Development Authority (BARDA) in April 2012. In his previous role as a BARDA Project Officer, Chris lead multiple interdisciplinary product development teams responsible for advancing the development, manufacture, clinical and non-clinical evaluation, and regulatory approval of novel drugs against multidrug resistant organisms, emerging infectious diseases and biothreat agents. In …

CARB-X: The largest public-private partnership in the world is all about AMR

The largest public-private partnership in the world has been formed, and its purpose is progress in the fight against antimicrobial resistance. As discussed in a Contagion article, ‘World’s Largest Partnership Formed to Fight Antimicrobial Resistance‘, the US Department of Health and Human Services issued a press release announcing CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), a union of the Wellcome …

Michael Draper of Sanofi: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Dr. Michael Draper is currently the Senior Director of External Science and Partnering and a member of the Science, Strategy & External Innovation and Science Policy group at Sanofi. He has more than 15 years of research and development experience in the pharmaceutical industry at both large and small pharmaceutical companies. After completing his postdoctoral studies, he joined the organization …

Edmund Pezalla of Aetna: Featured Speaker at World Anti-Microbial Resistance Congress USA 2016

Edmund Pezalla, M.D., MPH, is Aetna’s National Medical Director for Pharmaceutical Policy and Strategy. He is responsible for the integration of pharmacy policy and activities into Aetna’s overall strategy and operations. Dr. Pezalla also serves as the lead clinical spokesperson for Aetna in pharmacy related issues and represents Aetna on industry work groups and conferences. Dr. Pezalla is Aetna’s leading …

CARB-O Loading: BARDA's Efforts to Revitalize the Antibiotic Pipeline

“CARB-O Loading: BARDA’s Efforts to Revitalize the Antibiotic Pipeline”

Melissa Stundick, PhD, Chief of Anti-Infectives Branch of the US Department of Health and Human Services joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘BARDA’s efforts to revitalize the antibiotic pipeline’ . In this presentation, learn about why BARDA is funding antibacterial development, as well as BARDA’S vision for 2016 and beyond . Download this presentation to …

Cepheid to sponsor World Anti-Microbial Resistance Congress USA 2016

Cepheid is the leading innovator in the field of molecular diagnostics. The Company is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use systems and tests. By automating highly complex procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated molecular testing that can dramatically enhance the management of infectious diseases …